Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 2.381B
March 31, 2026 2.449B
December 31, 2025 2.456B
September 30, 2025 2.432B
June 30, 2025 1.804B
March 31, 2025 1.817B
December 31, 2024 1.781B
September 30, 2024 1.807B
June 30, 2024 1.789B
March 31, 2024 1.415B
December 31, 2023 1.377B
September 30, 2023 1.209B
June 30, 2023 1.231B
March 31, 2023 1.180B
December 31, 2022 1.114B
September 30, 2022 937.00M
June 30, 2022 970.50M
March 31, 2022 1.017B
December 31, 2021 1.070B
September 30, 2021 1.076B
June 30, 2021 1.002B
March 31, 2021 967.70M
December 31, 2020 961.20M
September 30, 2020 952.10M
June 30, 2020 897.40M
Date Value
March 31, 2020 915.60M
December 31, 2019 906.80M
September 30, 2019 845.20M
June 30, 2019 860.80M
March 31, 2019 913.20M
December 31, 2018 896.60M
September 30, 2018 816.90M
June 30, 2018 776.60M
March 31, 2018 781.50M
December 31, 2017 725.40M
September 30, 2017 731.80M
June 30, 2017 755.70M
March 31, 2017 724.70M
December 31, 2016 686.40M
September 30, 2016 693.90M
June 30, 2016 663.30M
March 31, 2016 702.10M
December 31, 2015 726.10M
September 30, 2015 760.30M
June 30, 2015 760.90M
March 31, 2015 715.80M
December 31, 2014 765.90M
September 30, 2014 807.50M
June 30, 2014 880.30M
March 31, 2014 862.60M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 52.68B
Agilent Technologies, Inc. 7.122B
Bio-Rad Laboratories, Inc. 7.174B
Danaher Corp. 52.58B
Illumina, Inc. 2.838B

Shareholders Equity (Quarterly) Related Metrics